ReviewClinical drug investigation2020

Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug-Drug Interactions.

Sauzanne Khalilieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.